Hence, additional studies are needed to confirm if there indeed is a decrease of D2-R in thalamus in schizophrenia, preferably using high-affinity radioligands in samples not affected by antipsychotic drug treatment and other confounders stemming from chronical illness. This evidence concerns the gene DRD2 and schizophrenia.